These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 38807208
21. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. Chan WL, Lukig ML, Liew FY. J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536 [Abstract] [Full Text] [Related]
26. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge. Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT. J Virol; 2015 Jan 01; 89(1):83-96. PubMed ID: 25320297 [Abstract] [Full Text] [Related]
27. Monoclonal anti-idiotypes to herpes simplex virus type 1 capable of antigen specific priming & stimulatory activity. Dar VS, Seth P. Indian J Med Res; 1993 Sep 01; 97():187-90. PubMed ID: 7505259 [Abstract] [Full Text] [Related]
28. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD. Baghian A, Chouljenko VN, D'Auvergne O, Newman MJ, Baghian S, Kousoulas KG. J Med Microbiol; 2002 Apr 01; 51(4):350-357. PubMed ID: 11926742 [Abstract] [Full Text] [Related]
29. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs. Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM. PLoS Pathog; 2018 May 01; 14(5):e1007095. PubMed ID: 29791513 [Abstract] [Full Text] [Related]
31. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells. Treat BR, Bidula SM, Ramachandran S, St Leger AJ, Hendricks RL, Kinchington PR. PLoS Pathog; 2017 Dec 01; 13(12):e1006732. PubMed ID: 29206240 [Abstract] [Full Text] [Related]
32. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. J Virol; 2008 Jul 01; 82(14):6935-41. PubMed ID: 18480440 [Abstract] [Full Text] [Related]
33. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Ritchie MH, Oakes JE, Lausch RN. Invest Ophthalmol Vis Sci; 1993 Jul 01; 34(8):2460-8. PubMed ID: 8392037 [Abstract] [Full Text] [Related]
34. Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4+ and CD8+ TRM Cells Associated with Protection against Recurrent Genital Herpes. Srivastava R, Roy S, Coulon PG, Vahed H, Prakash S, Dhanushkodi N, Kim GJ, Fouladi MA, Campo J, Teng AA, Liang X, Schaefer H, BenMohamed L. J Virol; 2019 May 01; 93(9):. PubMed ID: 30787156 [Abstract] [Full Text] [Related]
35. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K, Namazue J, Campo-Vera H, Ogino T, Yamanishi K. Virology; 1986 Feb 01; 149(1):74-82. PubMed ID: 2418583 [Abstract] [Full Text] [Related]